|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn855714282 |
003 |
OCoLC |
005 |
20231117044914.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
980319s1973 enka ob 001 0 eng d |
040 |
|
|
|a KIJ
|b eng
|e pn
|c KIJ
|d OCLCO
|d OCLCF
|d OPELS
|d OCLCQ
|d OCLCO
|d OCLCQ
|d UAB
|d STF
|d UKAHL
|d VLY
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1162018467
|
020 |
|
|
|a 9780433126409
|q (electronic bk.)
|
020 |
|
|
|a 043312640X
|q (electronic bk.)
|
020 |
|
|
|a 1483141756
|
020 |
|
|
|a 9781483141756
|
035 |
|
|
|a (OCoLC)855714282
|z (OCoLC)1162018467
|
050 |
|
4 |
|a RS190.I5
|
060 |
|
4 |
|a WB354
|b GRO
|
082 |
0 |
4 |
|a 615.63
|
100 |
1 |
|
|a Groves, M. J.
|q (Michael John)
|
245 |
1 |
0 |
|a Parenteral products :
|b the preparation and quality control of products for injection /
|c by M.J. Groves.
|
260 |
|
|
|a London :
|b Heinemann Medical,
|c 1973.
|
300 |
|
|
|a 1 online resource (vi, 316 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a Parenteral Products: The Preparation and Quality Control of Products for Injection deals with modern pharmaceutical practice in the preparation, quality control, and storage of injectable drug solutions. The book gives a basic background of parenteral solutions, the routes of administration, the effects of the different administrations of injection solutions, and the formulation of these products.
|
505 |
0 |
|
|a Front Cover; Parenteral Products; Copyright Page; Dedication; Preface; Table of Contents; Chapter 1. Perspective on the Use of Parenteral Solutions; INTRODUCTION; ROUTES OF ADMINISTRATION; THE EFFECT OF ROUTE ON THE DURATION OF DRUG ACTIVITY; THE 'HYDROSPRAY' INJECTOR; THE ORIGINS OF THE INTRAVENOUS THERAPY; THE DEVELOPMENT OF HYPODERMIC MEDICATION; THE STERILIZATION OF INJECTION SOLUTIONS; THE UNITED STATES PHARMACOPOEIAL CLARITY TEST; REFERENCES; Chapter 2. The Formulation of Parenteral Products; UNITS; THE TONICITY OF INJECTION SOLUTIONS; THE ELECTROLYTE COMPOSITION OF BODY FLUIDS
|
505 |
8 |
|
|a THEORIES OF FILTRATIONMECHANISM OF PARTICLE CAPTURE; THE RELATIVE ADVANTAGES AND DISADVANTAGES OF SCREEN AND DEPTH FILTERS; PRETREATMENT; THE CRITERIA OF AN IDEAL FILTER; THE CHOICE OF FILTRATION MEDIA; CELLULOSE PAPERS; ASBESTOS PADS AND PAPERS; SINTERED GLASS FILTERS; SINTERED METAL FILTERS; GLASS PAPERS; MEMBRANE FILTERS; PREPARATION OF A MEMBRANE FILTER; THE STRUCTURE OF CELLULOSE MEMBRANE FILTERS; THE MECHANISMS OF MEMBRANE FILTRATION; THE TESTING OF MEMBRANE FILTERS; THE ADVANTAGES OF MEMBRANE FILTERS; THE TYPES AND SHAPES OF MEMBRANE FILTERS AT PRESENT AVAILABLE
|
505 |
8 |
|
|a DISCUSSION: THE CHOICE OF A FILTRATION SYSTEM FOR PARENTERAL PRODUCTSREFERENCES; Chapter 4. Sterilization; INTRODUCTION; THE MEANING OF STERILIZATION; METHODS OF STERILIZATION DESTRUCTION; 'KILLING' OR INACTIVATION; PHYSICAL REMOVAL; THE KINETICS OF MICROBIAL DEATH INTRODUCTION; FIRST ORDER OF REACTION; THERMAL DEATH TIME; DECIMAL REDUCTION TIME (D VALUE); THERMAL DESTRUCTION VALUE (Z VALUE); THE Q-10 VALUE; INACTIVATION FACTORS; THE NON-KINETIC F VALUE; FACTORS AFFECTING THE SURVIVAL OF MICRO-ORGANISMS; THE CONTROL OF STERILIZATION PROCESSES; THE STEAM AUTOCLAVE INTRODUCTION
|
505 |
8 |
|
|a VACUUM-PURGED AUTOCLAVES AND BALLASTED AUTOCLAVESSPRAY COOLED AUTOCLAVES; DISADVANTAGES OF DISCONTINUOUS AUTOCLAVES; CONTINUOUS AUTOCLAVES INTRODUCTION; THE 'HYDROMATIC' STERILIZER; THE ECONOMICS OF CONTINUOUS AUTOCLAVING; OVERPRESSURE STERILIZERS; REFERENCES; Chapter 5. The Working Environment; INTRODUCTION; THE MANUFACTURING PROCESS STRUCTURE OF A PHARMACEUTICAL MANUFACTURER; THE ECONOMICS OF PRODUCTION; THE ASSEMBLY OF CONSTITUENTS AND COMPONENTS; MANUFACTURING; THE IMPORTANCE OF QUALITY CONTROL; CODES OF GOOD MANUFACTURING PRACTICE; CLEAN WATER INTRODUCTION; 'WATER FOR INJECTIONS'
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Injections
|x Standards.
|
650 |
|
0 |
|a Parenteral therapy.
|
650 |
0 |
2 |
|a Infusions, Parenteral
|0 (DNLM)D007263
|
650 |
0 |
2 |
|a Injections
|x standards
|0 (DNLM)D007267Q000592
|
650 |
|
6 |
|a Injections
|0 (CaQQLa)201-0023326
|x Normes.
|0 (CaQQLa)201-0373964
|
650 |
|
6 |
|a M�edicaments
|x Administration parent�erale.
|0 (CaQQLa)201-0037133
|
650 |
|
7 |
|a Parenteral therapy
|2 fast
|0 (OCoLC)fst01053391
|
650 |
|
7 |
|a Injections
|x Standards
|2 fast
|0 (OCoLC)fst00973525
|
776 |
|
|
|z 1-322-46679-3
|
776 |
|
|
|z 0-433-12640-X
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780433126409
|z Texto completo
|